CANAVERAL MEDICINES Trademark

Trademark Overview


On Friday, January 17, 2025, a trademark application was filed for CANAVERAL MEDICINES with the United States Patent and Trademark Office. The USPTO has given the CANAVERAL MEDICINES trademark a serial number of 99005500. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Tuesday, November 11, 2025. This trademark is owned by Canaveral Medicines, Inc.. The CANAVERAL MEDICINES trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Biological preparations, namely, nucleic acids, proteins, and peptides for medical and veterinary purposes; Chemical and biological diagnostic preparations and substances, namely, nucleic acids, proteins and polypeptides, small molecules for medical or veterinary purposes in clinical and medical laboratory use in drug discovery and nucleic acid and protein therapeutics in the bio-pharmaceutical industry; Nucleic acid-protein conjugates for medical or veterinary purposes; Nucleic acids for medical purposes; Nucleic acid therapeutic pharmaceuticals for the treatment of extra-hepatic disease; nucleic acid and protein therapeutics, namely, proteins designed to deliver highly targeted therapeutic modulation for patients suffering from a variety of diseases, namely, autoimmune and inflammatory diseases, metabolic diseases, cancer, chronic kidney diseases, rare diseases, genetic diseases, respiratory diseases, and infectious diseases; Pharmaceutical preparations, namely, nucleic acid and prot...

Biotechnology, medical and scientific research, and development services in the field of nucleic acid and protein therapeutics and diagnostics; Biotechnology research services, namely, nucleic acid and protein therapeutics development for applications in the lung, pediatric, gastrointestinal, reproductive, kidney, metabolic, infectious disease, cancer, immunological, and genetic disciplines; Medical and scientific research and development services in the field of nucleic acid and protein therapeutics and diagnostics; Research and development of medicines; Pharmaceutical research and development services in the field of nucleic acid and protein therapeutics.
canaveral medicines

General Information


Serial Number99005500
Word MarkCANAVERAL MEDICINES
Filing DateFriday, January 17, 2025
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateTuesday, November 11, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 2, 2025

Trademark Statements


Goods and ServicesBiological preparations, namely, nucleic acids, proteins, and peptides for medical and veterinary purposes; Chemical and biological diagnostic preparations and substances, namely, nucleic acids, proteins and polypeptides, small molecules for medical or veterinary purposes in clinical and medical laboratory use in drug discovery and nucleic acid and protein therapeutics in the bio-pharmaceutical industry; Nucleic acid-protein conjugates for medical or veterinary purposes; Nucleic acids for medical purposes; Nucleic acid therapeutic pharmaceuticals for the treatment of extra-hepatic disease; nucleic acid and protein therapeutics, namely, proteins designed to deliver highly targeted therapeutic modulation for patients suffering from a variety of diseases, namely, autoimmune and inflammatory diseases, metabolic diseases, cancer, chronic kidney diseases, rare diseases, genetic diseases, respiratory diseases, and infectious diseases; Pharmaceutical preparations, namely, nucleic acid and protein therapeutics for the treatment of a variety of diseases, namely, autoimmune and inflammatory diseases, metabolic diseases, cancer, chronic kidney diseases, rare diseases, genetic diseases, respiratory diseases, and infectious diseases; Pharmaceuticals using protein biotherapeutics to treat a variety of diseases, namely, autoimmune and inflammatory diseases, metabolic diseases, cancer, chronic kidney diseases, rare diseases, genetic diseases, respiratory diseases, and infectious diseases; Pharmaceutical preparations containing nucleic acid and protein therapeutics for the treatment of immune system, infectious disease, pulmonary diseases and disorders, genetic diseases, metabolic diseases, kidney diseases, reproductive disorders, gastrointestinal diseases, cancers, and obesity; Protein therapeutic pharmaceuticals for the treatment of human conditions, namely a variety of diseases, namely, autoimmune and inflammatory diseases, metabolic diseases, cancer, chronic kidney diseases, rare diseases, genetic diseases, respiratory diseases, and infectious diseases.
Goods and ServicesBiotechnology, medical and scientific research, and development services in the field of nucleic acid and protein therapeutics and diagnostics; Biotechnology research services, namely, nucleic acid and protein therapeutics development for applications in the lung, pediatric, gastrointestinal, reproductive, kidney, metabolic, infectious disease, cancer, immunological, and genetic disciplines; Medical and scientific research and development services in the field of nucleic acid and protein therapeutics and diagnostics; Research and development of medicines; Pharmaceutical research and development services in the field of nucleic acid and protein therapeutics.
NOT AVAILABLE"MEDICINES"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, January 17, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, January 17, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCanaveral Medicines, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02116

Trademark Events


Event DateEvent Description
Friday, January 17, 2025NEW APPLICATION ENTERED
Thursday, June 19, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 26, 2025ASSIGNED TO EXAMINER
Saturday, August 9, 2025NON-FINAL ACTION WRITTEN
Saturday, August 9, 2025NON-FINAL ACTION E-MAILED
Saturday, August 9, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, October 31, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, October 31, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, October 31, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, November 1, 2025APPROVED FOR PUB - PRINCIPAL REGISTER